Mitigating the Off-target Effects in CRISPR/Cas9-mediated Genetic Editing with Bioinformatic Technologies

Shixing Yuan

doi:10.62051/dpgwbz03

Authors

Shixing Yuan

DOI:

https://doi.org/10.62051/dpgwbz03

Keywords:

CRISPR/Cas9; off-target effects; bioinformatics technology; sgRNA design; genetic editing.

Abstract

The biological and clinical fields have recognized the CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/CRISPR associated protein 9) system as a precise and efficient tool for editing the genome. Despite its merits, the system poses crucial challenges, notably the off-target effects which could lead to unintended mutations - a substantial impediment for clinical applications that may potentially compromise the validity of research and the safety of therapeutic applications. Bioinformatics plays a pivotal role in mitigating this risk. Utilizing more refined bioinformatic tools and algorithms, researchers can reduce off-target mutations remarkably. These instruments, powered by machine learning and computational modelling, are able to predict off-target effects and provide aid for the design of more efficient sgRNA. Despite these advancements, it remains crucial to continue to focus on the improvement and assessment of such bioinformatics strategies. This review aims to holistically explore the mechanism and applications of CRISPR/Cas9 genome editing, its off-target effects, and the consequent impacts, along with the potential of bioinformatics techniques to identify off-target risks and facilitate sgRNA design. This review will also incorporate a clinical trial on HIV-1 treatment as a case study to highlight the potential of bioinformatics in devising solutions to mitigate the potential off-target effects of CRISPR/Cas9-mediated genetic editing.

Downloads

Download data is not yet available.

References

Hajiahmadi, Z., Movahedi, A., Wei, H., Li, D., Orooji, Y., Ruan, H., & Zhuge, Q. (2019). Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR/Cas9 System in Plants. International Journal of Molecular Sciences, 20 (15), Article 15.

Jiang, F., & Doudna, J. A. (2017). CRISPR-Cas9 Structures and Mechanisms. Annual Review of Biophysics, 46, 505 – 529. https: //doi.org/10.1146/annurev-biophys - 062215 - 010822.

Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014). Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature, 513 (7519), 569 – 573.

Zhang, X.-H., Tee, L. Y., Wang, X.-G., Huang, Q.-S., & Yang, S.-H. (2015). Off-target Effects in CRISPR/Cas9-mediated Genome Engineering. Molecular Therapy - Nucleic Acids, 4, e264.

Zhang, J.-H., Adikaram, P., Pandey, M., Genis, A., & Simonds, W. F. (2016). Optimization of genome editing through CRISPR-Cas9 engineering. Bioengineered, 7(3), 166 – 174.

Beying, N., Schmidt, C., & Puchta, H. (2021). Double strand break (DSB) repair pathways in plants and their application in genome engineering. London: Dodds Science Publishing, 27 – 62.

Přibylová, A., Fischer, L., Pyott, D. E., Bassett, A., & Molnar, A. (2022). DNA methylation can alter CRISPR/Cas9 editing frequency and DNA repair outcome in a target‐specific manner. The New Phytologist, 235 (6), 2285 – 2299.

Wolt, J. D., Wang, K., Sashital, D., & Lawrence‐Dill, C. J. (2016). Achieving Plant CRISPR Targeting that Limits Off‐Target Effects. The Plant Genome, 9 (3), plantgenome2016. 05. 0047.

Naeem, M., & Alkhnbashi, O. S. (2023). Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects. International Journal of Molecular Sciences, 24 (7), Article 7.

Cornet, C., Di Donato, V., & Terriente, J. (2018). Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline. Frontiers in Pharmacology, 9, 703.

Smith, C., Abalde-Atristain, L., He, C., Brodsky, B. R., Braunstein, E. M., Chaudhari, P., Jang, Y.-Y., Cheng, L., & Ye, Z. (2015). Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs. Molecular Therapy, 23 (3), 570 – 577.

Cox, D. B. T., Platt, R. J., & Zhang, F. (2015). Therapeutic genome editing: Prospects and challenges. Nature Medicine, 21 (2), 121 – 131.

Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014). Genetic Screens in Human Cells Using the CRISPR-Cas9 System. Science, 343 (6166), 80 – 84.

Matano, M., Date, S., Shimokawa, M., Takano, A., Fujii, M., Ohta, Y., Watanabe, T., Kanai, T., & Sato, T. (2015). Modelling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids. Nature Medicine, 21 (3), 256 – 262. https://doi.org/10.1038/nm.3802

Wu, S.-S., Li, Q.-C., Yin, C.-Q., Xue, W., & Song, C.-Q. (2020a). Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases. Theranostics, 10 (10), 4374 – 4382.

Khatodia, S., Bhatotia, K., Passricha, N., Khurana, S. M. P., & Tuteja, N. (2016). The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops. Frontiers in Plant Science, 7.

Selvakumar, S. C., Preethi, K. A., Ross, K., Tusubira, D., Khan, M. W. A., Mani, P., Rao, T. N., & Sekar, D. (2022). CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer. Molecular Cancer, 21 (1), 83.

Feng, W., Dai, Y., Mou, L., Cooper, D., Shi, D., & Cai, Z. (2015). The Potential of the Combination of CRISPR/Cas9 and Pluripotent Stem Cells to Provide Human Organs from Chimaeric Pigs. International Journal of Molecular Sciences, 16 (12), 6545 – 6556.

Cui, Y., Xu, J., Cheng, M., Liao, X.-K., & Peng, S. (2018). Review of CRISPR/Cas9 sgRNA Design Tools. Interdisciplinary Sciences: Computational Life Sciences, 10.

Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., Cradick, T. J., Marraffini, L. A., Bao, G., & Zhang, F. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology, 31 (9), 827 – 832.

Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013). High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nature Biotechnology, 31 (9), 839 – 843.

Zhang, Q., Xing, H.-L., Wang, Z.-P., Zhang, H.-Y., Yang, F., Wang, X.-C., & Chen, Q.-J. (2018). Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention. Plant Molecular Biology, 96 (4–5), 445 – 456.

Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014). Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA. Cell, 156 (5), 935 – 949.

Feng, W., Dai, Y., Mou, L., Cooper, D., Shi, D., & Cai, Z. (2015). The Potential of the Combination of CRISPR/Cas9 and Pluripotent Stem Cells to Provide Human Organs from Chimaeric Pigs. International Journal of Molecular Sciences, 16 (12), 6545 – 6556.

Shen, H., Strunks, G. D., Klemann, B. J. P. M., Hooykaas, P. J. J., & de Pater, S. (2017). CRISPR/Cas9-Induced Double-Strand Break Repair in Arabidopsis Nonhomologous End-Joining Mutants. G3 Genes|Genomes|Genetics, 7 (1), 193 – 202.

Corrigan-Curay, J., O’Reilly, M., Kohn, D. B., Cannon, P. M., Bao, G., Bushman, F. D., Carroll, D., Cathomen, T., Joung, J. K., Roth, D., Sadelain, M., Scharenberg, A. M., Von Kalle, C., Zhang, F., Jambou, R., Rosenthal, E., Hassani, M., Singh, A., & Porteus, M. H. (2015). Genome Editing Technologies: Defining a Path to Clinic. Molecular Therapy, 23 (5), 796 – 806.

Kosicki, M., Tomberg, K., & Bradley, A. (2018). Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements. Nature Biotechnology, 36 (8), 765 – 771.

Haapaniemi, E., Botla, S., Persson, J., Schmierer, B., & Taipale, J. (2018). CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response. Nature Medicine, 24 (7), 927 – 930. https://doi.org/10.1038/s41591-018-0049-z.

Monteys, A. M., Ebanks, S. A., Keiser, M. S., & Davidson, B. L. (2017). CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo. Molecular Therapy: The Journal of the American Society of Gene Therapy, 25 (1), 12 – 23.

Koo, T., Lee, J., & Kim, J.-S. (2015). Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9. Molecules and Cells, 38 (6), 475 – 481.

Li, H. (2013). Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM (arXiv:1303.3997). arXiv.

Bae, S., Park, J., & Kim, J.-S. (2014). Cas-OFFinder: A fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics (Oxford, England), 30 (10), 1473 – 1475.

Fu, R., He, W., Dou, J., Villarreal, O. D., Bedford, E., Wang, H., Hou, C., Zhang, L., Wang, Y., Ma, D., Chen, Y., Gao, X., Depken, M., & Xu, H. (2022). Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity. Nature Communications, 13 (1), 474.

Liang, S.-Q., Liu, P., Smith, J. L., Mintzer, E., Maitland, S., Dong, X., Yang, Q., Lee, J., Haynes, C. M., Zhu, L. J., Watts, J. K., Sontheimer, E. J., Wolfe, S. A., & Xue, W. (2022). Genome-wide detection of CRISPR editing in vivo using GUIDE-tag. Nature Communications, 13 (1), 437.

Thomas, M., Parry-Smith, D., & Iyer, V. (2019). Best practice for CRISPR design using current tools and resources. Methods, 164 – 165, 3 – 17.

Concordet, J.-P., & Haeussler, M. (2018). CRISPOR: Intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Research, 46 (W1), W242 – W245.

Xu, L., Yang, H., Gao, Y., Chen, Z., Xie, L., Liu, Y., Liu, Y., Wang, X., Li, H., Lai, W., He, Y., Yao, A., Ma, L., Shao, Y., Zhang, B., Wang, C., Chen, H., & Deng, H. (2017). CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo. Molecular Therapy, 25 (8), 1782 – 1789.

Moreno-Mateos, M. A., Vejnar, C. E., Beaudoin, J.-D., Fernandez, J. P., Mis, E. K., Khokha, M. K., & Giraldez, A. J. (2015). CRISPRscan: Designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nature Methods, 12 (10), 982 – 988.

Upadhyay, S. K., & Sharma, S. (2014). SSFinder: High Throughput CRISPR-Cas Target Sites Prediction Tool. BioMed Research International, 2014, 1 – 4.

Akcakaya, P., Bobbin, M. L., Guo, J. A., Malagon-Lopez, J., Clement, K., Garcia, S. P., Fellows, M. D., Porritt, M. J., Firth, M. A., Carreras, A., Baccega, T., Seeliger, F., Bjursell, M., Tsai, S. Q., Nguyen, N. T., Nitsch, R., Mayr, L. M., Pinello, L., Bohlooly-Y, M., … Joung, J. K. (2018). In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature, 561(7723), 416 – 419.